Analyst Activity – Maxim Group Reiterates Hold on Amedica (NASDAQ:AMDA)

Analyst Ratings For Amedica (NASDAQ:AMDA)

Story continues below

Today, Maxim Group reiterated its Hold rating on Amedica (NASDAQ:AMDA).

Some recent analyst ratings include

  • 1/24/2018-Maxim Group Reiterated Rating of Hold.
  • 11/27/2017-Ladenburg Thalmann Financial Services was Downgraded by analysts at Ladenburg Thalmann Financial Services from a “Buy ” rating to a ” Neutral” rating.

Recent Insider Trading Activity For Amedica (NASDAQ:AMDA)
Amedica (NASDAQ:AMDA) has insider ownership of 0.10% and institutional ownership of 62.51%.

  • On 9/10/2015 Ty Lombardi, VP, bought 25,000 with an average share price of $0.40 per share and the total transaction amounting to $10,000.00.
  • On 12/11/2014 David W Truetzel, Director, sold 15,000 with an average share price of $0.68 per share and the total transaction amounting to $10,200.00.
  • On 12/8/2014 Jeffrey S White, Director, bought 9,600 with an average share price of $0.62 per share and the total transaction amounting to $5,952.00.
  • On 2/18/2014 David W Truetzel, Director, bought 5,000 with an average share price of $5.82 per share and the total transaction amounting to $29,100.00.

Recent Trading Activity for Amedica (NASDAQ:AMDA)
Shares of Amedica closed the previous trading session at 3.40 down -0.02 0.45% with shares trading hands.

An ad to help with our costs